Tenon Medical, Inc.
TNON
$1.46
$0.4443.14%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 4.29% | 12.25% | 32.59% | 31.32% | 33.03% |
| Total Depreciation and Amortization | 18.97% | 53.76% | 76.55% | 72.26% | 64.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -9.75% | -6.25% | -9.42% | -4.20% | -24.55% |
| Change in Net Operating Assets | 48.93% | 36.40% | -111.85% | -152.22% | -150.87% |
| Cash from Operations | 8.42% | 18.92% | 29.43% | 24.80% | 16.69% |
| Capital Expenditure | 83.08% | 48.48% | 63.79% | 69.89% | 50.68% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | -93.61% | 203.67% |
| Cash from Investing | -104.95% | -103.03% | -103.67% | -96.70% | 154.36% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 66.22% | 34.40% | 35.64% | -42.95% | -46.59% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -72.44% | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 497.11% | 753.83% | 1,199.44% | -251.19% | -5,215.38% |
| Cash from Financing | 49.44% | 124.14% | 213.55% | 29.48% | -24.15% |
| Foreign Exchange rate Adjustments | -100.00% | 21.05% | 251.72% | 7.46% | 2,025.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 389.91% | 1,273.58% | 2,556.42% | -91.99% | 180.71% |